Philipp Niehues
University of Münster
8 Papers
17 Citations
Philipp Niehues is an academic researcher from University of Münster. The author has contributed to research in topics: Medicine & QT interval. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model.
Christian Ellermann,Alix Coenen,Philipp Niehues,Patrick Leitz,Simon Kochhäuser,Dirk G. Dechering,Michael Fehr,Lars Eckardt,Gerrit Frommeyer +8 more
TL;DR: In the present study, donepezil and galantamine provoked triggered activity, whereas rivastigmine did not have proarrhythmic effects, and the need for further electrocardiographic risk predictors is emphasized.
15
Accuracy of Deep Learning Echocardiographic View Classification in Patients with Congenital or Structural Heart Disease: Importance of Specific Datasets
Felix K. Wegner,M. L. Benesch Vidal,Philipp Niehues,Kevin Willy,Robert M Radke,Philipp D. Garthe,Lars Eckardt,Helmut Baumgartner,Gerhard-Paul Diller,Stefan Orwat +9 more
TL;DR: This study is the first to validate view classification by neural networks in C/SHD patients and achieves a considerably increased accuracy in this particular cohort.
Incidence and predictors of cardiac arrhythmias in patients with COVID-19 induced ARDS
Philipp Niehues,Felix K. Wegner,Julian Wolfes,Kevin Willy,Christian Ellermann,Richard Vollenberg,Holger Reinecke,Felix Rosenow,Johannes Lepper,Jan Sackarnd,Lars Eckardt +10 more
TL;DR: In this paper , the authors evaluate the risk of potentially lethal arrhythmias and atrial fibrillation in patients with COVID-19-induced acute respiratory distress syndrome (ARDS) and elicit possible predictors of arrhythmia occurrence.
9
Use of Direct Oral Anticoagulants in Patients on Chronic Hemodialysis: Contemporary Appraisal on the Role for Patients with Atrial Fibrillation.
Philipp Niehues,Julian Wolfes,Felix K. Wegner,Christian Ellermann,Benjamin Rath,L. Eckardt +5 more
TL;DR: This review appraises the use of direct oral anticoagulants in hemodialysis patients with atrial fibrillation, highlighting the challenges of oral anticoagulation in this population and summarizing existing data on the benefits and risks of VKA and DOAC therapy.
6
[Atrial fibrillation in patients with sepsis and non-cardiac infections].
TL;DR: The question of whether this group of patients benefits from long-term effective anticoagulation and extended monitoring of arrhythmia should be the subject of future research.
4